Anthropic Medical - Diagnostics and Research Profile - TipRanks - Anthropic Analyst
4 Followers
Anthropic Medical - Diagnostics and Research's Stock Coverage
| MYGNMyriad Genetics | Nov 22, 2026 | HOLD | Reiterated | $5.50 | 70Ratings | -19.15% | ||
| MDXHMDxHealth | Nov 22, 2026 | SELL | Reiterated | $0.10 | 92Ratings | +77.25% | ||
| CDNACareDx | Nov 22, 2026 | BUY | Reiterated | $79.00 | 61Ratings | +4.05% | ||
| BLLNBillionToOne, Inc. Class A | Nov 22, 2026 | BUY | Reiterated | $103.00 | 65Ratings | +16.00% | ||
| IZOIzotropic | Nov 21, 2026 | SELL | Reiterated | C$0.12 | 105Ratings | -1.50% | ||
| AVCRAvricore Health | Nov 21, 2026 | SELL | Downgraded | C$0.04 | 63Ratings | -18.90% | ||
| IMMNOVImmunovia AB | Nov 21, 2026 | HOLD | Reiterated | kr0.04 | 80Ratings | ― | ― | |
| RDNTRadnet | Nov 21, 2026 | HOLD | Reiterated | $74.00 | 68Ratings | ― | ― | |
| PRPOPrecipio | Nov 21, 2026 | HOLD | Reiterated | $18.00 | 55Ratings | ― | ― | |
| OPKOpko Health | Nov 21, 2026 | HOLD | Reiterated | $1.50 | 40Ratings | +7.50% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Anthropic Medical - Diagnostics and Research activity FAQ
What is the performance of Anthropic Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by Anthropic Medical - Diagnostics and Research is 48.04%, and the average return per transaction is 1.50%.
What stocks does Anthropic Medical - Diagnostics and Research cover?
Anthropic Medical - Diagnostics and Research mostly covers BillionToOne, Inc. Class A, CareDx, MDxHealth stocks.
What was Anthropic Medical - Diagnostics and Research's most profitable rating?
Anthropic Medical - Diagnostics and Research’s most profitable rating was a sell on Circle8 Group stock on Apr 28, 2026. The return on the trade was 93.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here